Tag: radiation oncology

New Investigational Helmet Device Shrinks Glioblastoma

A case report describes a novel helmet device that generates a noninvasive oscillating magnetic field and that shrunk a glioblastoma tumor by about a third....

Recent Cyberattack Disrupted Cancer Care Throughout US

Cyberhacking of healthcare organizations are on the increase, and a recent cyberattack affected oncology care across the United States when hackers disrupted the software for...

Kathy O’Brien, Critic of Cancer Bell Ringing, Dies at 56

Katherine O’Brien, who lived with metastatic breast cancer for 12 years and left her mark on American cancer care, died June 19 after a rapid...

Blood Test for Multiple Cancers ― Too Many False Positives?

New data on the Galleri blood test (from Grail) show that it detected a cancer signal for a broad range of cancer types and that...

Better Survival After Lumpectomy Plus RT vs Mastectomy

Overall survival and breast cancer–specific survival were consistently better for women with early breast cancer who were treated with breast conservation surgery (BCS) followed by...

Negative Results When Immunotherapy Was Added Onto Radiation

The early halt of a phase 3 trial of avelumab (Bavencio) plus chemoradiotherapy for the treatment of squamous cell head and neck cancer raises a...

Cancer Screening Stopped by Pandemic: Repercussions to Come?

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Last year, cancer screening programs around the world ground to a...

Weight Gain Common in Childhood Brain Tumor Survivors

Children who have been treated for brain tumors often experience significant weight gain, and new findings suggest that this could be a sign of hypothalamic-pituitary...

FDA Approves Cemiplimab-rwlc for NSCLC With PD-L1 Expression

The US Food and Drug Administration (FDA) has approved cemiplimab-rwlc (Libtayo) for the treatment of advanced non–small cell lung cancer (NSCLC). Specifically, the indication is...

CCR Score Can Guide Treatment After Radiation in Prostate Cancer

The combined clinical cell-cycle risk (CCR) score — derived from both clinical and genetic factors — can identify patients with intermediate- and high-risk localized prostate...

Doctors Underreport Side Effects of Breast Irradiation

There is a substantial mismatch between patient and physician reports of toxicity during radiotherapy for breast cancer, according to an analysis of nearly 10,000 U.S....

New Standard Emerges for Locally Advanced Rectal Cancer

A new approach to the treatment of patients with high-risk, locally advanced rectal cancer reduces the rate of treatment failure, and may also increase rate...

Palbociclib Disappoints in HR+, HER2– Breast Cancer

The CDK4/6 inhibitor palbociclib provides no significant benefit in patients with hormone receptor–positive (HR+), HER2-negative primary breast cancer, according to first results from the PENELOPE-B...

Beta-Blocker May Improve Melanoma Treatment Response

Response rates were high without dose-limiting toxicities in a small phase 1 study that evaluated the addition of propranolol to pembrolizumab in treatment-naive patients with...

Cancer Rates on the Rise in Adolescents and Young Adults

Rates of cancer increased by 30% from 1973 to 2015 in adolescents and young adults (AYAs) (persons aged 15–39 years) in the United States, according...

FDA Approves First Agent for PSMA-PET Imaging in Prostate Cancer

A new radioactive diagnostic agent for use in prostate cancer has been approved by the US Food and Drug Administration (FDA). The product, Gallium 68...

SRS Instead of WBRT for Patients With Multiple Brain Metastases

Stereotactic radiosurgery (SRS) should replace whole-brain radiotherapy (WBRT) as the new standard of care for patients with four or more brain metastases, say researchers who...

Surveillance After CRC Resection Does Not Improve Survival

Intensive surveillance with carcinoembryonic antigen (CEA) testing and CT scans after colorectal cancer resection did not improve recurrence-free or overall survival when compared with standard...

Hold Off Radiotherapy After Prostate Cancer Surgery

Most men who undergo radical prostatectomy can skip adjuvant radiotherapy and can be followed with observation alone. They can undergo early salvage radiotherapy if the...

Survey Quantifies COVID-19’s Impact on Oncology

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. An international survey provides new insights into how COVID-19 has affected,...

Threefold Higher Risk for Breast Cancer Death With DCIS

For women diagnosed with ductal carcinoma in situ (DCIS), the risk of dying of breast cancer was three times higher than among women in the...

Medicare Will Test Pay Models for Radiation Oncology, Dialysis

Beginning in 2021, Medicare will test alternative methods of paying for radiation oncology and dialysis, with the giant federal insurer saying it is seeking to...

Readers Predict Biggest Medical Breakthroughs by 2045

When Medscape’s readers were asked to predict medical breakthroughs in the next quarter century, the most common responses zeroed in on the human genome. Altering...

NBA Star in the Orlando Bubble

Editor’s Note: This transcript from the August 20 episode of the Blood & Cancer podcast has been edited for clarity. Click this link to listen...

In a First, Proton Therapy Bests Radiotherapy in an RCT

In a first, proton beam therapy has demonstrated significantly reduced toxicity when compared with conventional radiotherapy in a randomized controlled trial (RCT) in patients with...